COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn PVP-IPVP-I REGNREGN LY-CoVLY RemdesivirRMD
Vitamin D study #8 of 50
6/30 Analysis of outcomes based on serum levels
Panagiotou et al., medRxiv, doi:10.1101/2020.06.21.20136903 (Peer Reviewed)
Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity: results of a local audit of practice
Source   PDF   Share   Tweet
Retrospective analysis 134 hospitalized patients. 19% of ICU patients had 25(OH)D levels > 50 nmol/L vs. 39.1% of non-ICU patients, p=0.02

Panagiotou et al., 6/30/2020, retrospective, United Kingdom, Europe, peer-reviewed, 12 authors.
risk of ICU admission, 52.0% lower, RR 0.48, p = 0.02, treatment 8 of 44 (18.2%), control 34 of 90 (37.8%), >50nmol/L.
Details of all 50 studies
Please submit corrections, updates, or comments.